AAHS ASPN ASRM - 2013 Annual Meeting - American Association ...
AAHS ASPN ASRM - 2013 Annual Meeting - American Association ...
AAHS ASPN ASRM - 2013 Annual Meeting - American Association ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>ASRM</strong> Concurrent Scientific Paper Presentatons C-1<br />
A New Composite Tissue Allograft Transplantation Model for Reconstruction of the Head and Neck Defects and<br />
Long Term Survival Permitted by Donor Specific Chimerism Under Low Dose Cyclosporine A Treatment<br />
Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />
Yalcin Kulahci; Aleksandra Klimczak; Maria Siemionow; The Cleveland Clinic Foundation<br />
Background:<br />
Extensive head and neck deformities including bone and soft tissue defects are always challenging for reconstructive surgeons. The purpose of this study was<br />
to extend application of the face/scalp transplantation model in rat by incorporation of the vascularized mandible, masseter and tongue, based on the same<br />
vascular pedicle, as a new reconstructive option for extensive head and neck deformities with large soft and bone tissue defects.<br />
Methods:<br />
A total of 12 composite osseomusculocutaneous hemiface/mandible-tongue transplantations were performed in two experimental groups. Group 1 isotransplantation<br />
between Lewis rats served as control without treatment (n=6). Group 2 (n=6) composite hemiface/mandible-tongue transplants were performed<br />
across MHC barrier between Lewis-Brown Norway (LBN, RT11+n) donors and Lewis (RT11) recipients. Hemifacial flaps including hemimandibular bone, masseter<br />
muscle and tongue were dissected on the same pedicle of external carotid artery and jugular vein and were transplanted to the donor inguinal region.<br />
All allogenic transplant recipients received 16mg/kg/day of CsA monotheraphy tapered to 2 mg/kg/day and maintained at this level thereafter. All animals were<br />
monitored for sign of allograft rejection such as erythema, edema, hair loss, desquamation. Flap angiography and CT scan evaluated allograft viability. Flow<br />
cytometry assessed donor-specific chimerism for MHC class I- RT1n antigen. H&E staining revealed bone histology, hemotopoietic activity and tested inflammatory<br />
response and grade of allograft rejection.<br />
Results:<br />
Isograft controls survived indefinitely. Six hemiface/mandible-tongue allotransplants survived up to 200 days (still under observation). Flap angiography demonstrated<br />
intact vascular supply to the bone. No signs of rejection and no flap loss were noted. CT scan and bone histology confirmed viability of bone components<br />
of the composite allografts. Viability of tongue was confirmed by pink color, bleeding after puncture and histology. H+E staining determined the presence<br />
of viable bone marrow cells within transplanted mandible. Donor-specific chimerism at day 100 posttransplant was established for by presence of donor<br />
T-cells (2.7% CD4/RT1n, 1.2% CD8/RT1n) and B-cells (11.5% CD45RA/RT1n).<br />
Conclusions:<br />
We have introduced a new model of composite osseomusculocutaneous hemiface/mandible-tongue allograft transplant. Long-term allograft acceptance was<br />
accompanied by presence of donor specific chimerism supported by vascularized bone marrow transplant of the mandibular component. This model may serve<br />
as a new reconstructive option for coverage of the extensive head and neck deformities involving large bone and soft tissue defects performed in one-stage<br />
surgical procedure.<br />
Potential Approaches to Face Harvest for Face Transplantation<br />
Institution where the work was prepared: Duke University Medical Center, Durham, NC, USA<br />
Alessio Baccarani, MD; Keith E. Follmar; Jeffrey R. Marcus; Detlev Erdmann; L. Scott Levin; Duke University<br />
Background:<br />
Total face transplantation has begun to emerge as a reconstructive option in the treatment of patients with massive facial disfigurement. The challenges associated<br />
with immunosuppression and the ethical issues surrounding face transplantation are substantial. One of the most significant technical questions that<br />
remains to be answered before the first total face transplant can be performed is how a facial allograft would be harvested and what tissues it would include.<br />
We present two novel face harvesting techniques based on our understanding of the vascular anatomy.<br />
Methods:<br />
The first technique harvests the skin and soft tissue of the face by dissecting in a subgaleal, sub-SMAS, subplatysmal plane. The second technique harvests the<br />
entire soft tissue and bony structure of the face by dissecting in a subperiosteal plane and harvesting the bones of the midface by performing a Le Fort III<br />
osteotomy. These techniques were performed on fresh human cadavers that had been perfused with latex.<br />
Results:<br />
Each face was harvested successfully as a bipedicled flap based on the external carotid arteries, the external jugular veins, and the facial veins. The sub-SMAS<br />
flap appeared to be well perfused by the external carotid system throughout. The subperiosteal Le Fort III flap appeared to be well perfused everywhere except<br />
for portions of the zygomatic arch and the sphenoid bone.<br />
Conclusions:<br />
Each of these two techniques is a theoretically viable approach to face harvesting for face transplantation and they address different reconstructive needs.<br />
Substantial challenges remain before face transplantation can become a viable reconstructive option.<br />
161